» Articles » PMID: 18676520

Growth of Children on Classical and Medium-chain Triglyceride Ketogenic Diets

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2008 Aug 5
PMID 18676520
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objectives of this study were to examine growth in children on classical and medium-chain triglyceride ketogenic diets and to investigate any association between growth and calorie or protein intake.

Methods: Weight, height, and BMI z scores were recorded for children who were initiated on 1 of 2 ketogenic diets at baseline and after 3, 6, and 12 months, if continued. Mean calorie and protein intakes during treatment were calculated for children who completed 12 months on the diet. Changes in growth were compared between the 2 diets, and the association between growth and dietary intake was examined.

Results: Seventy-five children provided growth data. Weight z scores decreased significantly between baseline and 3, 6, and 12 months; height z scores showed no change at 3 months but decreased significantly by 6 and 12 months. This was more significant in the younger and ambulatory children. Subdivision according to diet type showed weight z scores to decrease significantly in the medium-chain triglyceride group only at 3 and 6 months and in both groups at 12 months. Height z scores decreased significantly in both groups by 6 and 12 months. Forty children completed 12 months of treatment; in this group, the slopes of best-fit regression lines of serial z-score measures were used to represent growth trend. There were no significant differences in mean slope between classical and medium-chain triglyceride diet groups for weight, height, or BMI. There was no significant difference in mean calorie intake during the 12 months between the 2 diets, but the medium-chain triglyceride group had significantly higher protein intake. There was no significant correlation between calorie or protein intakes and the slope of the best-fit line for weight, height, or BMI.

Conclusions: Both weight and height z scores decreased during diet treatment. By 12 months, there was no difference in outcome between classical and medium-chain triglyceride protocols despite the increased protein in the latter diet.

Citing Articles

Ketogenic diet and β-hydroxybutyrate in osteoporosis: current progress and controversy.

Luo C, Dai Z, He W, He Y, Yang P, Huang M Front Nutr. 2025; 12:1508695.

PMID: 39917743 PMC: 11798809. DOI: 10.3389/fnut.2025.1508695.


Diagnosis and treatment of growth hormone deficiency in children on the ketogenic diet: A case series.

Groveman S, Klepper J, Liesenkotter K, Grimberg A, Bergqvist A Epilepsia Open. 2024; 9(3):1096-1102.

PMID: 38642014 PMC: 11145606. DOI: 10.1002/epi4.12942.


The impact of ketogenic diet on some metabolic and non-metabolic diseases: Evidence from human and animal model experiments.

Galali Y, Zebari S, Aj Jabbar A, Balaky H, Sadee B, Hassanzadeh H Food Sci Nutr. 2024; 12(3):1444-1464.

PMID: 38455178 PMC: 10916642. DOI: 10.1002/fsn3.3873.


Ketogenic diet for epilepsy control and enhancement in adaptive behavior.

El-Rashidy O, Nassar M, Shokair W, El Gendy Y Sci Rep. 2023; 13(1):2102.

PMID: 36747012 PMC: 9902473. DOI: 10.1038/s41598-023-27373-1.


Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.

Ruiz Herrero J, Canedo Villarroya E, Gutierrez-Solana L, Garcia Alcolea B, Gomez Fernandez B, Puerta Macfarland L Nutrients. 2021; 13(3).

PMID: 33806661 PMC: 8000344. DOI: 10.3390/nu13030840.